Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue

被引:17
作者
Smith, RA
Lea, RA
Curran, JE
Weinstein, SR
Griffiths, LR
机构
[1] Griffith Univ Gold Coast, Genom Res Ctr, Sch Hlth Sci, Southport, Qld 9726, Australia
[2] Griffith Univ Gold Coast, Wesley Res Inst, Southport, Qld, Australia
[3] Gold Coast Hosp, Dept Pathol, Southport, Qld, Australia
关键词
breast cancer; glucocorticoid receptor; nuclear receptors; progesterone receptor;
D O I
10.1186/bcr556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Previous studies in our laboratory have shown associations of specific nuclear receptor gene variants with sporadic breast cancer. In order to investigate these findings further, we conducted the present study to determine whether expression levels of the progesterone and glucocorticoid nuclear receptor genes vary in different breast cancer grades. Methods: RNA was extracted from paraffin-embedded archival breast tumour tissue and converted into cDNA. Sample cDNA underwent PCR using labelled primers to enable quantitation of mRNA expression. Expression data were normalized against the 18S ribosomal gene multiplex and analyzed using analysis of variance. Results: Analysis of variance indicated a variable level of expression of both genes with regard to breast cancer grade (P = 0.00033 for glucocorticoid receptor and P = 0.023 for progesterone receptor). Conclusion: Statistical analysis indicated that expression of the progesterone nuclear receptor is elevated in late grade breast cancer tissue.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer
    Xiaohong R. Yang
    Jonine D. Figueroa
    Stephen M. Hewitt
    Roni T. Falk
    Ruth M. Pfeiffer
    Jolanta Lissowska
    Beata Peplonska
    Louise A. Brinton
    Montserrat Garcia-Closas
    Mark E. Sherman
    Breast Cancer Research and Treatment, 2013, 137 : 837 - 847
  • [32] Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer
    Yang, Xiaohong R.
    Figueroa, Jonine D.
    Hewitt, Stephen M.
    Falk, Roni T.
    Pfeiffer, Ruth M.
    Lissowska, Jolanta
    Peplonska, Beata
    Brinton, Louise A.
    Garcia-Closas, Montserrat
    Sherman, Mark E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (03) : 837 - 847
  • [33] Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor
    Bendrat, Klaus
    Fritz, Peter
    Mueller, Simon
    Brockmoeller, Sylvia
    Debus, Annegret
    Friedrichs, Kay
    Lindner, Christoph
    Brinkmann, Friedhelm
    Heidemann, Else
    Niendorf, Axel
    ANTICANCER RESEARCH, 2016, 36 (08) : 3855 - 3863
  • [34] Expression of Prostate Apoptosis Response (Par-4) Is Associated with Progesterone Receptor in Breast Cancer
    Zapata-Benavides, Pablo
    Mendez-Vazquez, Jose L.
    Gonzalez-Rocha, Talina R.
    Zamora-Avila, Diana E.
    Franco-Molina, Moises A.
    Garza-Garza, Raul
    Rodriguez-Padilla, Cristina
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (07) : 595 - 599
  • [35] Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
    Kalinina, Tatiana
    Kononchuk, Vladislav
    Alekseenok, Efim
    Obukhova, Darya
    Sidorov, Sergey
    Strunkin, Dmitry
    Gulyaeva, Lyudmila
    GENES, 2021, 12 (04)
  • [36] Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
    Das, Kakoli
    Leong, David Tai
    Gupta, Anurag
    Shen, Liang
    Putti, Thomas
    Stein, Gary S.
    van Wijnen, Andre J.
    Salto-Tellez, Manuel
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) : 2239 - 2248
  • [37] Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
    T. J. A. Dekker
    S. ter Borg
    G. K. J. Hooijer
    S. L. Meijer
    J. Wesseling
    J. E. Boers
    E. Schuuring
    J. Bart
    J. van Gorp
    P. Bult
    S. A. Riemersma
    C. H. M. van Deurzen
    H. F. B. M. Sleddens
    W. E. Mesker
    J. R. Kroep
    V. T. H. B. M. Smit
    M. J. van de Vijver
    Breast Cancer Research and Treatment, 2015, 152 : 247 - 252
  • [38] Progesterone receptor modulators in breast cancer
    Wiehle, Ronald D.
    TURKISH JOURNAL OF BIOLOGY, 2014, 38 (06) : 772 - 785
  • [39] Incorporating progesterone receptor expression into the PREDICT breast prognostic model
    Grootes, Isabelle
    Keeman, Renske
    Blows, Fiona M.
    Milne, Roger L.
    Giles, Graham G.
    Swerdlow, Anthony J.
    Fasching, Peter A.
    Abubakar, Mustapha
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Beckmann, Matthias W.
    Blomqvist, Carl
    Bojesen, Stig E.
    Bolla, Manjeet K.
    Bonanni, Bernardo
    Briceno, Ignacio
    Burwinkel, Barbara
    Camp, Nicola J.
    Castelao, Jose E.
    Choi, Ji-Yeob
    Clarke, Christine L.
    Couch, Fergus J.
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Devilee, Peter
    Dork, Thilo
    Dunning, Alison M.
    Dwek, Miriam
    Easton, Douglas F.
    Eccles, Diana M.
    Eriksson, Mikael
    Ernst, Kristina
    Evans, D. Gareth
    Figueroa, Jonine D.
    Fink, Visnja
    Floris, Giuseppe
    Fox, Stephen
    Gabrielson, Marike
    Gago-Dominguez, Manuela
    Garcia-Saenz, Jose A.
    Gonzalez-Neira, Anna
    Haeberle, Lothar
    Haiman, Christopher A.
    Hall, Per
    Hamann, Ute
    Harkness, Elaine F.
    Hartman, Mikael
    Hein, Alexander
    Hooning, Maartje J.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 178 - 193
  • [40] Progesterone receptor isoform functions in normal breast development and breast cancer
    Kariagina, Anastasia
    Aupperlee, Mark D.
    Haslam, Sandra Z.
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2008, 18 (01): : 11 - 33